Tumor Microenvironment Analysis Using Curated Data and Modeling
About this webinar
Understanding the tumor microenvironment (TME) presents a major challenge for biopharma researchers and translational scientists. The complexity of cellular interactions, variability across patient samples and overwhelming volume of public omics data can make it challenging to pinpoint key molecular drivers and predict functional consequences. Building a clear, actionable view of the TME often feels like assembling a puzzle without the picture on the box.
In this webinar, discover how to overcome these challenges by combining expertly curated biological knowledge with powerful predictive modeling tools. Learn how to easily construct molecular networks, interpret gene expression data from resources like The Cancer Genome Atlas and Gene Expression Omnibus and model upstream regulators to predict immune and tumor behavior. Using examples such as Interleukin-1 beta’s role in non-small cell lung cancer (NSCLC), the featured speaker will show how to accelerate discoveries and guide therapeutic insights.
Register for this webinar to learn how predictive modeling and data curation reveal key insights into the tumor microenvironment.
Who should attend
- Lab Directors
- Bioinformaticians
- Young scientists
- Biologists
- Data Scientists
- Preclinical Researchers
- Scientists in pharma and biotech
What you will learn
- How to identify disease-associated molecules and visualize their biological interactions
- How to mine and interpret public gene expression data for deeper insights into cancer biology
- How to model upstream regulators and predict functional outcomes within the TME
Featured Speakers
Kristin O’Malley
Kristin O’Malley has spent much of her career at the bench in genomics labs in the clinical space, large pharmaceutical companies and small start-up biotechs. She took this experience and switched careers a few years ago to become a Field Application Scientist. She enjoys the broad spectrum of biology she encounters in this role and empowering scientists to be successful in their endeavors.
Partner for this event
QIAGEN
For 25 years, QIAGEN Digital Insights has led the way in genomic content and bioinformatic solutions—setting the gold standard that others only strive to match. Offering trusted tools for research, clinical and biopharma applications, our content-powered solutions are unmatched in depth, quality and accuracy.
We combine expert curation with AI-powered literature extraction to deliver insights that drive real scientific breakthroughs. With 90,000+ users and over 4.5 million NGS patient test cases globally, QDI is the partner of choice for national health programs, top universities, and leading labs. To shape the future, you need a partner with a legacy of excellence. That partner is QDI.
Related webinars
More from QIAGEN.
Reduce Discovery Risk Using Comorbidity Data, Omics and Knowledge Graphs
Leveraging Rapid Multiplex Testing During the Height of Respiratory Season
Liquid Biopsy Workflow Optimization for Improved Assay Sensitivity and Multianalyte Applications of Cell-Free RNA, DNA and CTCs
The Impact of Multiplex Testing for Respiratory Infections in North America
Tackling the Diagnosis of Respiratory Infections During COVID-19 Using a Multiplex PCR Assay
RNA Biomarker Development: From Sample to Insight
Exosome RNA for Biomarker Development
Revisiting the Central Dogma of Molecular Biology at the Genome Scale and in Single Cells
Total RNA Discovery: Studying Gene Expression One Transcript at a Time